Nexpoint住宅信托 NXRT 深 沪
等待开盘 04-01 09:30:00 美东时间
25.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 25.00
- 总市值 6.35亿
- 52周最高 36.85
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.851
- 委 比 0.00%
- 总股本 2541.13万
- 历史最高 87.6503
- 量 比 0
- 振 幅 0.00%
- 历史最低 -4.0127
- 每 手 1
- 风险率 2.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
Truist Securities Maintains Hold on NexPoint Residential Tr, Lowers Price Target to $27
Truist Securities analyst Michael Lewis maintains NexPoint Residential Tr (NYSE:NXRT) with a Hold and lowers the price target from $30 to $27.
03-13 01:09
Raymond James Downgrades NexPoint Residential to Underperform
Raymond James analyst Buck Horne downgrades NexPoint Residential (NYSE:NXRT) from Market Perform to Underperform.
02-28 02:05
NexPoint Residential Sees FY2026 FFO $2.57 vs $2.39 Est
NexPoint Residential (NYSE:NXRT) is looking for FY2026 FFO of $2.57 vs $2.39 analyst estimate..
02-24 21:18
Earnings Breakdown: NexPoint Residential Q4
The Q4 earnings report for NexPoint Residential (NYSE:NXRT) was released on Tue...
02-24 21:18
NexPoint Residential Q4 FFO $0.65 Beats $0.61 Estimate, Sales $62.100M Miss $62.810M Estimate
NexPoint Residential (NYSE:NXRT) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.61 by 6.04 percent. This is a 4.41 percent decrease over earnings of $0.68 per share from
02-24 21:17
NexPoint Residential Trust, Inc. Announces Quarterly Dividend
DALLAS, Feb. 24, 2026 /PRNewswire/ -- NexPoint Residential Trust, Inc. (NYSE: NXRT) ("NXRT") announced today that its board of directors unanimously approved a dividend of $0.53 per share of...
02-24 21:15
Earnings Scheduled For February 24, 2026
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Truist Securities Maintains Hold on NexPoint Residential, Lowers Price Target to $30
Truist Securities analyst Michael Lewis maintains NexPoint Residential (NYSE:NXRT) with a Hold and lowers the price target from $31 to $30.
01-20 21:03
